{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T17:52:03Z","timestamp":1790358723952,"version":"4.1.0"},"reference-count":45,"publisher":"Elsevier BV","issue":"1-3","license":[{"start":{"date-parts":[[2009,10,1]],"date-time":"2009-10-01T00:00:00Z","timestamp":1254355200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Schizophrenia Research"],"published-print":{"date-parts":[[2009,10]]},"DOI":"10.1016\/j.schres.2009.07.012","type":"journal-article","created":{"date-parts":[[2009,8,20]],"date-time":"2009-08-20T04:29:07Z","timestamp":1250742547000},"page":"6-16","source":"Crossref","is-referenced-by-count":64,"title":["Schizophrenia and breast cancer incidence"],"prefix":"10.1016","volume":"114","author":[{"given":"Chris J.","family":"Bushe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew J.","family":"Bradley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiram J.","family":"Wildgust","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard E.","family":"Hodgson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.schres.2009.07.012_bib1","series-title":"Textbook of Medical Record Linkage","author":"Baldwin","year":"1987"},{"issue":"12","key":"10.1016\/j.schres.2009.07.012_bib2","doi-asserted-by":"crossref","first-page":"2817","DOI":"10.1002\/cncr.21574","article-title":"Reduced cancer incidence among patients with schizophrenia","volume":"104","author":"Barak","year":"2005","journal-title":"Cancer"},{"issue":"1\u20133","key":"10.1016\/j.schres.2009.07.012_bib3","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.schres.2008.03.017","article-title":"Breast cancer in women suffering from serious mental illness","volume":"102","author":"Barak","year":"2008","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.schres.2009.07.012_bib4","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1177\/0269881107075509","article-title":"Minimising metabolic and cardiovascular risk in schizophrenia: diabetes, obesity and dyslipidaemia","volume":"21","author":"Barnett","year":"2007","journal-title":"J. Psychopharmacol."},{"issue":"7","key":"10.1016\/j.schres.2009.07.012_bib5","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1177\/0269881107078281","article-title":"Prevalence of hyperprolactinaemia in a naturalistic cohort of schizophrenia and bipolar outpatients during treatment with typical and atypical antipsychotics","volume":"21","author":"Bushe","year":"2007","journal-title":"J. Psychopharmacol."},{"issue":"2 Suppl","key":"10.1016\/j.schres.2009.07.012_bib6","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1177\/0269881107088435","article-title":"A review of the association between antipsychotic use and hyperprolactinaemia","volume":"22","author":"Bushe","year":"2008","journal-title":"J. Psychopharmacol."},{"issue":"5","key":"10.1016\/j.schres.2009.07.012_bib7","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1111\/j.1600-0447.2008.01163.x","article-title":"Cancer incidence in patients with schizophrenia and their first-degree relatives \u2014 a meta-analysis","volume":"117","author":"Catts","year":"2008","journal-title":"Acta Psychiatr. Scand."},{"issue":"9229","key":"10.1016\/j.schres.2009.07.012_bib8","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1016\/S0140-6736(00)02593-9","article-title":"Trends in breast cancer incidence, survival, and mortality","volume":"356","author":"Coleman","year":"2000","journal-title":"Lancet"},{"issue":"1\u20132","key":"10.1016\/j.schres.2009.07.012_bib44","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0920-9964(02)00430-9","article-title":"Schizophrenia and the risk for breast cancer","volume":"62","author":"Dalton","year":"2003","journal-title":"Schizophr. Res."},{"issue":"5","key":"10.1016\/j.schres.2009.07.012_bib9","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1176\/appi.ajp.161.5.903","article-title":"Risk for cancer in parents of patients with schizophrenia","volume":"161","author":"Dalton","year":"2004","journal-title":"Am. J. Psychiatry"},{"issue":"2\u20133","key":"10.1016\/j.schres.2009.07.012_bib10","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.schres.2004.11.009","article-title":"Risk for cancer in a cohort of patients hospitalized for schizophrenia in Denmark, 1969\u20131993","volume":"75","author":"Dalton","year":"2005","journal-title":"Schizophr. Res."},{"issue":"95 (7)","key":"10.1016\/j.schres.2009.07.012_bib11","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1038\/sj.bjc.6603259","article-title":"Cancer risk among users of neuroleptic medication: a population-based cohort study","volume":"9","author":"Dalton","year":"2006","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.schres.2009.07.012_bib12","series-title":"Psychiatric Case Registers in Public Health","first-page":"229","article-title":"Incidence of cancer in patients diagnosed as schizophrenic in Denmark","author":"Dupont","year":"1986"},{"key":"10.1016\/j.schres.2009.07.012_bib13","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1192\/bjp.187.4.334","article-title":"Schizophrenia and cancer: an epidemiological study","volume":"187","author":"Goldacre","year":"2005","journal-title":"Br. J. Psychiatry."},{"issue":"5","key":"10.1016\/j.schres.2009.07.012_bib45","first-page":"107","article-title":"Long term phenothiazine use and breast and pancreatic cancer in Scottish in-patients","author":"Gray","year":"1991","journal-title":"Pharmaceut. Med"},{"key":"10.1016\/j.schres.2009.07.012_bib14","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.schres.2004.06.016","article-title":"Cancer in schizophrenia: is the risk higher or lower","volume":"73","author":"Grinshpoon","year":"2005","journal-title":"Schizophr. Res."},{"issue":"18","key":"10.1016\/j.schres.2009.07.012_bib15","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1192\/S0007125000297080","article-title":"Cancer incidence of schizophrenic patients. Results of record linkage studies in three countries","author":"Gulbinat","year":"1992","journal-title":"Br. J. Psychiatry Suppl."},{"issue":"4","key":"10.1016\/j.schres.2009.07.012_bib16","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1176\/ajp.153.4.559","article-title":"Are chronic psychiatric patients at increased risk for developing breast cancer?","volume":"153","author":"Halbreich","year":"1996","journal-title":"Am. J. Psychiatry"},{"issue":"2 Suppl","key":"10.1016\/j.schres.2009.07.012_bib17","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1177\/0269881107082624","article-title":"Adverse effects of prolactin in rodents and humans: breast and prostate cancer","volume":"22","author":"Harvey","year":"2008","journal-title":"J. Psychopharm."},{"issue":"6","key":"10.1016\/j.schres.2009.07.012_bib18","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1093\/annonc\/mdn025","article-title":"Quantification of changes in breast cancer incidence and mortality since 1990 in 35 countries with Caucasian-majority populations","volume":"19","author":"H\u00e9ry","year":"2008","journal-title":"Ann. Oncol."},{"issue":"12","key":"10.1016\/j.schres.2009.07.012_bib19","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1001\/archpsyc.64.12.1368","article-title":"Risk of malignancy in patients with schizophrenia or bipolar disorder: nested case\u2013control study","volume":"64","author":"Hippisley-Cox","year":"2007","journal-title":"Arch. Gen. Psychiatry"},{"issue":"6","key":"10.1016\/j.schres.2009.07.012_bib20","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1001\/archpsyc.58.6.579","article-title":"Schizophrenia and cancer: is there a need to invoke a protective gene?","volume":"58","author":"Jablensky","year":"2001","journal-title":"Arch. Gen. Psychiatry"},{"issue":"5","key":"10.1016\/j.schres.2009.07.012_bib21","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1034\/j.1600-0447.2000.101005382.x","article-title":"Excess cancer mortality in Western Australian psychiatric patients due to higher case fatality rates","volume":"101","author":"Lawrence","year":"2000","journal-title":"Acta Psychiatr. Scand."},{"issue":"2 Suppl","key":"10.1016\/j.schres.2009.07.012_bib22","first-page":"1","article-title":"American Psychiatric Association; Steering Committee on Practice Guidelines 2004. Practice guideline for the treatment of patients with schizophrenia, second edition","volume":"161","author":"Lehman","year":"2004","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.schres.2009.07.012_bib23","series-title":"A Review of the Evidence","first-page":"86","article-title":"Physical illness and schizophrenia","author":"Leucht","year":"2007"},{"key":"10.1016\/j.schres.2009.07.012_bib24","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1192\/bjp.bp.106.024943","article-title":"Cancer risk among parents and siblings of patients with schizophrenia","volume":"190","author":"Levav","year":"2007","journal-title":"Br. J. Psychiatry"},{"issue":"6","key":"10.1016\/j.schres.2009.07.012_bib25","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1001\/archpsyc.58.6.573","article-title":"Incidence of cancer among persons with schizophrenia and their relatives","volume":"58","author":"Lichtermann","year":"2001","journal-title":"Arch. Gen. Psychiatry"},{"issue":"6","key":"10.1016\/j.schres.2009.07.012_bib26","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/1471-244X-6-49","article-title":"Mammography stages of change in middle-aged women with schizophrenia: an exploratory analysis","volume":"30","author":"Lindamer","year":"2006","journal-title":"BMC Psychiatry"},{"issue":"1","key":"10.1016\/j.schres.2009.07.012_bib27","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1136\/jech.43.1.43","article-title":"The incidence of cancer in schizophrenic patients","volume":"43","author":"Mortensen","year":"1989","journal-title":"J. Epidemiol. Commun. Health"},{"issue":"3","key":"10.1016\/j.schres.2009.07.012_bib28","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/0920-9964(94)90028-0","article-title":"The occurrence of cancer in first admitted schizophrenic patients","volume":"12","author":"Mortensen","year":"1994","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.schres.2009.07.012_bib29","series-title":"Psychiatric Case Registers in Public Health","first-page":"240","article-title":"The example of a linkage with a cancer register","author":"Nakane","year":"1986"},{"key":"10.1016\/j.schres.2009.07.012_bib30","series-title":"Breast Screening Programme, England 2006\u20137","author":"NHS","year":"2008"},{"key":"10.1016\/j.schres.2009.07.012_bib31","series-title":"Audit of Screen Detected Breast Cancers 2006\u20137","author":"NHS UK","year":"2008"},{"key":"10.1016\/j.schres.2009.07.012_bib33","series-title":"Cancer Statistics Registrations: Registrations of Cancer Diagnosed in 2004, England","author":"Office for National Statistics","year":"2007"},{"issue":"1\u20132","key":"10.1016\/j.schres.2009.07.012_bib34","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0920-9964(02)00430-9","article-title":"Schizophrenia and the risk for breast cancer","volume":"62","author":"Oksbjerg Dalton","year":"2003","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.schres.2009.07.012_bib35","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1001\/archpsyc.64.2.242","article-title":"Relative risk of cardiovascular and cancer mortality in people with severe mental illness from the United Kingdom's General Practice Research Database","volume":"64","author":"Osborn","year":"2007","journal-title":"Arch. Gen. Psychiatry"},{"issue":"7","key":"10.1016\/j.schres.2009.07.012_bib36","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.eurpsy.2007.07.002","article-title":"A well-being programme in severe mental illness. Reducing risk for physical ill-health: a post-programme service evaluation at 2\u00a0years","volume":"22","author":"Smith","year":"2007","journal-title":"Eur. Psychiatry"},{"issue":"15","key":"10.1016\/j.schres.2009.07.012_bib37","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1001\/jama.283.15.2008","article-title":"Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis of Observational Studies in Epidemiology (MOOSE) group","volume":"283","author":"Stroup","year":"2000","journal-title":"JAMA"},{"key":"10.1016\/j.schres.2009.07.012_bib38","series-title":"The South London and Maudsley NHS Foundation Trust and Oxleas NHS Foundation Trust Prescribing Guidelines","author":"Taylor","year":"2007"},{"key":"10.1016\/j.schres.2009.07.012_bib39","doi-asserted-by":"crossref","first-page":"6814","DOI":"10.1158\/0008-5472.CAN-04-1870","article-title":"Plasma prolactin concentrations and risk of postmenopausal breast cancer","volume":"64","author":"Tworoger","year":"2004","journal-title":"Cancer Res."},{"issue":"12","key":"10.1016\/j.schres.2009.07.012_bib40","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1200\/JCO.2006.07.6356","article-title":"A prospective study of plasma prolactin concentrations and the risk of premenopausal and postmenopausal breast cancer","volume":"25","author":"Tworoger","year":"2007","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.schres.2009.07.012_bib41","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.canlet.2006.01.032","article-title":"Prolactin and breast cancer risk","volume":"243","author":"Tworoger","year":"2006","journal-title":"Cancer Lett."},{"issue":"9","key":"10.1016\/j.schres.2009.07.012_bib46","first-page":"2703","article-title":"Breast cancer at a psychiatric hospital before and after the introduction of neuroleptic agents","volume":"38","author":"Wagner","year":"1978","journal-title":"Cancer Res."},{"key":"10.1016\/j.schres.2009.07.012_bib42","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1001\/archpsyc.59.12.1147","article-title":"Dopamine antagonists and the development of breast cancer","volume":"59","author":"Wang","year":"2002","journal-title":"Arch. Gen. Psychiatry"},{"issue":"7","key":"10.1016\/j.schres.2009.07.012_bib43","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1136\/jech.2005.039065","article-title":"Uptake of screening for breast cancer in patients with mental health problems","volume":"60","author":"Werneke","year":"2006","journal-title":"J. Epidemiol. Commun. Health"}],"container-title":["Schizophrenia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S092099640900334X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S092099640900334X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,21]],"date-time":"2019-05-21T23:05:09Z","timestamp":1558479909000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S092099640900334X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,10]]},"references-count":45,"journal-issue":{"issue":"1-3","published-print":{"date-parts":[[2009,10]]}},"alternative-id":["S092099640900334X"],"URL":"https:\/\/doi.org\/10.1016\/j.schres.2009.07.012","relation":{},"ISSN":["0920-9964"],"issn-type":[{"value":"0920-9964","type":"print"}],"subject":[],"published":{"date-parts":[[2009,10]]}}}